Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hedge Fund:444’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Broadfin Capital and Biodelivery Sciences International Inc (BDSI)

Biodelivery Sciences International Inc (NASDAQ:BDSI): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital&#......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13D Filing: Broadfin Capital and Novelion Therapeutics Inc. (NVLN)

Novelion Therapeutics Inc. (NASDAQ:NVLN): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
easiest countries to get oxycodone prescribed

13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Recro Pharma Inc. (NASDAQ:REPH): Kevin Kotler’s Broadfin Capital filed an amended 13D. You can check out Broadfin Capital’s latest holdings......(read more)
15 Biggest US Government Cover Ups of All Time

13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Broadfin Kevin Kotler

13G Filing: Broadfin Capital and Cidara Therapeutics Inc. (CDTX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: Broadfin Capital and Corium International Inc. (CORI)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
didesign021/Shutterstock.com

13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Broadfin Kevin Kotler

13G Filing: Broadfin Capital and Alphatec Holdings Inc. (NASDAQ:ATEC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Can hedge funds beat the market

140 Biggest and Most Famous Activist Hedge Funds

Some of the names we are going to show on this top 140 biggest and most famous activist hedge funds list are the investors that keep certain executives......(read more)
Broadfin Kevin Kotler

Qlt Inc (QLTI): Broadfin Capital Adds Another 820,000 Shares to its Position

We wrote recently about Qlt Inc (NASDAQ:QLTI) entering into an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger

Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc. and the latter’s subsidiary, Isotope Acquisition Corp., entered into an Agreement......(read more)
Broadfin Kevin Kotler

Qlt Inc (QLTI): Broadfin’s Kevin Kotler to Become Director of Novelion

In June, Qlt Inc (NASDAQ:QLTI) signed an Agreement and Plan of Merger with its wholly-owned indirect subsidiary, Isotope Acquisition Corp., and Aegerion......(read more)
Broadfin Kevin Kotler

Recro Pharma Inc. (REPH): Largest Shareholder Broadfin Capital Buys Even More Shares

An amended 13D filing with the Securities and Exchange Commission showed that Kevin Kotler‘s Broadfin Capital has acquired more shares of Recro......(read more)
Broadfin Kevin Kotler

Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others

Kevin Kotler‘s healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1

Though 2016 hasn’t been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused......(read more)
Broadfin Kevin Kotler

13G Filing: Broadfin Capital and Cardica Inc (CRDC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION......(read more)
Broadfin Kevin Kotler

Nevro Corp (NVRO): Broadfin Capital Jumps On February Swoon to Buy More Shares

Kevin Kotler‘s Broadfin Capital has filed a Form 13G disclosing an enlarged position of 1.46 million shares of Nevro Corp (NYSE:NVRO). The holding......(read more)
Most Popular Stocks Among Hedge Funds

Billionaire Icahn Salutes Xerox Corp (XRX)’s Split, Lasry Trims YRC Worldwide Inc. (YRCW) Stake, and Kotler Buys More Raptor Pharmaceutical Corp. (RPTP)

Although the average hedge fund has been struggling to beat broader market benchmarks in recent years, the hedge fund industry as a whole has been constantly......(read more)
Biggest Charities in USA

Bill & Melinda Gates Foundation Trust’s Latest Bet on China & Two Other Latest Hedge Fund Moves

At Insider Monkey, we focus mainly on the 13F filings of around 730 hedge funds and other institutional investors, in order to identify trading opportunities......(read more)
Jeff Smith

Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI)

Some bright minds of the finance world believe that shareholder activism has surged in recent years because of increased market efficiency. Hedge funds......(read more)
Broadfin Kevin Kotler

What Do Hedge Funds Have To Say About These 3 Purchases?

Most hedge funds and other money managers tracked by Insider Monkey have not submitted their 13F filings for the September quarter just yet. These public......(read more)
Broadfin Kevin Kotler

The Proxy Battle Between Broadfin Capital and Cardica (CRDC) Is Heating Up Just As New CEO Is Unveiled

The battle between Broadfin Capital and the Board of Cardica, Inc. (NASDAQ:CRDC) is heating up. As promised in a recent letter, Broadfin Capital and manager......(read more)
Broadfin Kevin Kotler

Hedge Funds See More Upside for Nevro Corp (NVRO) and WidePoint Corporation (WYY)

According to a recent 13G form filed with the Securities and Exchange Commission Kevin Kotler‘s (pictured) Broadfin Capital has added 1.18 million......(read more)
Broadfin Kevin Kotler

Contentious Proxy Battle Looms Between Broadfin Capital And Cardica, Inc. (CRDC)

Kevin Kotler‘s healthcare fund Broadfin Capital, the top performing fund in our database this year based on the calculated returns of its public......(read more)
Broadfin Kevin Kotler

Next Big Biotech Stock To Buy: Hedge Funds’ New Moves

Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge......(read more)
Broadfin Kevin Kotler

Broadfin Capital Increases Its Profitable Stake In Advaxis Inc. (ADXS) To 5.27%

As disclosed in a Schedule 13G filing with the U.S. Securities and Exchange Commission, Kevin Kotler’s Broadfin Capital holds an ownership stake of......(read more)
Broadfin Kevin Kotler

Broadfin Capital and Bridger Management Think SeaSpine Holdings Corp (SPNE) Is Oversold

According to two recent filings with the Securities and Exchange Commission, Kevin Kotler‘s (pictured) Broadfin Capital and Roberto Mignone‘......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Latest Move Lifts His Ownership In This Biotech Company To 5.92%

Kevin Kotler’s Broadfin Capital LLC, one of the leading healthcare-focused hedge funds, disclosed its ownership of nearly 1.48 million shares in Medgenics......(read more)
Broadfin Kevin Kotler

Healthcare Expert Kevin Kotler Boosts His Stake In Recro Pharma Inc. (REPH)

Kevin Kotler’s Broadfin Capital has filed a 13D with the Securities and Exchange Commission regarding its stake in Recro Pharma Inc. (NASDAQ:REPH).......(read more)
Broadfin Kevin Kotler

Broadfin Capital Discloses New Stake in This Canadian Biotechnology Company

Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S. Securities and Exchange......(read more)
Broadfin Kevin Kotler

Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths

According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler‘s Broadfin Capital has initiated a stake in ContraFect......(read more)
Broadfin Kevin Kotler

Alere Inc (ALR), Lion Biotech (LBIO), Genocea Biosciences Inc (GNCA), Advaxis Inc (ADXS) Among Broadfin’s Top New Health Picks

Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies. Kevin Kotler, a University......(read more)
Broadfin Kevin Kotler

Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside

To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......(read more)
Broadfin Kevin Kotler

Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains

Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).......(read more)
Broadfin Kevin Kotler

Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI)

In two separate filings today Kevin Kotler‘s Broadfin Capital has revealed increasing its passive stake in Zogenix, Inc. (NASDAQ:ZGNX) to 10.74......(read more)
Broadfin Kevin Kotler

Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions

The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......(read more)
Broadfin Kevin Kotler

Alcobra Ltd (ADHD): Broadfin Capital and Deerfield Initiate Passive Stakes Following Public Offering

Kevin Kotler’s Broadfin Capital and James Flynn’s Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD). As......(read more)
Broadfin Kevin Kotler

Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors

Kevin Kotler‘s New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). In a new filing with......(read more)
Broadfin Kevin Kotler

Cardica, Inc. (CRDC): Broadfin Capital Asks Other Shareholders to Support Its Crusade

Kevin Kotler’s Broadfin Capital doesn’t want to hear any more excuses from the Board of Cardica, Inc. (NASDAQ:CRDC) for under-performance, it want......(read more)
0000950157-11-000131_DHT-LOGO

DHT Holdings Inc (DHT), Titan Pharmaceuticals, Inc. (TTNP): Canyon Capital and Broadfin Capital Disclose Latest Moves

Canyon Capital Advisors, a fund led by Joshua Friedman and Mitchell Julis, disclosed boosting its position in DHT Holdings Inc (NYSE:DHT) to around......(read more)
Broadfin Kevin Kotler

PowerSecure International Inc. (POWR), Anthera Pharmaceuticals Inc (ANTH): Broadfin Capital and Becker Drapkin Management’s Recent Bullish Moves

Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH......(read more)
Rishi Bajaj - Altai Capital

Servicesource International Inc (SREV), Recro Pharma Inc (REPH): Altai Capital And Broadfin Capital’s Latest Moves

According to a recent filing with the Securities and Exchange Commission, Altai Capital, run by Rishi Bajaj, Toby Symonds and Steve Tesoriere, has increased......(read more)
Broadfin Kevin Kotler

Cardica Inc. (CRDC): Broadfin Capital, Kevin Kotler Send Another Letter To The Board

In a recent filing with the  Securities and Exchange Commission, Broadfin Capital has disclosed a letter sent to the Board of Directors of Cardica,......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Add Some More Cardica, Inc. (CRDC) Shares To Their Portfolio

Kevin Kotler and his fund, Broadfin Capital, have further boosted their holding of Cardica, Inc. (NASDAQ:CRDC) stock. According to a recent filing with......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)

Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)

In three recent filings,  Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital’s and MELA Sciences (MELA)

A new filing with the SEC revealed, Kevin Kotler and his hedge fund Broadfin Capital revealed a trimmed stake in MELA Sciences, Inc (NASDAQ:MELA).......(read more)